Cure First is a non profit 501 (c)(3) offering a CLIA certified functional drug sensitivity test applicable to all solid tumors. The PARIS® Test evaluates how a patient's own living tumor cells respond to potential therapies, providing individualized insights that may support treatment discussions. The test can be performed on any type of solid tumor, such as breast, colorectal, ovarian, prostate and many others, using a fresh surgical specimen, biopsies or body fluids. Cure First Laboratory is located in Bothell, WA. 98021.
Looking for a particular Cure First employee's phone or email?
Cure First Questions
Carla Grandori is the President and Scientific Director of Cure First.
11 people are employed at Cure First.
Cure First is based in Seattle, Washington.
The NAICS codes for Cure First are [54171, 541, 54, 541713, 5417].
The SIC codes for Cure First are [87, 873].
Top Cure First Employees
-
Carla Grandori
President and Scientific Director at Cure First
Seattle, WA, US15+ -
Christopher Kemp
Founder, Vice President at Cure First
Seattle, WA, US24 -
14
-
Robert Diaz
Director of Operations at Cure First
Kirkland, WA, US12 -
Payel Chatterjee
Director Medical Affairs at Cure First
Everett, WA, US12 -
21
-
Debra Dahlen
Senior Advisor at Cure First
Kirkland, WA, US1 -
Karo Majauskaite
Laboratory Manager at Cure First
Seattle, WA, US1 -
Pallem Vaishnavi
Clinical Research Coordinator at Cure First
Seattle, WA, US1
Related Companies
